Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Pharmacists should review care homes residents’ medicine regimens to reduce polypharmacy

April 25, 2019 Medical Communications care homes, older people, pharmacists, pharmacy, polypharmacy

Pharmacists should review older people’s medicines regimens in order to reduce inappropriate polypharmacy, according to the Royal Pharmaceutical Society (RPS). …
News

ICR calls for faster access to innovative cancer drugs

April 25, 2019 Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …
News

Interactions with the Agencies During Drug Development

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …
News
Press release
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
News

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
News
andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Appointment
about2medical

Medical cannabis: A green light for patients in need?

April 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Feature

Bayer VP elected to two of the firm’s executive committees

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Appointment
manabe

Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Appointment
darren_cline

GW Pharma announce Darren Cline as company’s new Chief Commercial Officer

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
Appointment
merckwindow_web

FDA expands Keytruda label to include stage 3 and 4 non-small cell lung cancer

April 12, 2019 Medical Communications, Research and Development Cancer, MSD, keytruda, lung cancer, non-small cell lung cancer, pharma

MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line …
News
janssen_latest_logo_on_sign_closer

Janssen’s Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis

April 12, 2019 Medical Communications HIV, Janssen, Symtuza, pharma

Janssen has lifted the curtain on data from the first Phase 3 trial investigating the efficacy of Symtuza (darunavir 800mg, …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
News
bacteria-3662695_960_720

Throat lozenges could be contributing to antimicrobial resistance

April 12, 2019 Medical Communications AMR, Antibiotics, OTC, WHO, antimicrobial, health

Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year’s …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026